Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors

Radotinib (IY5511HCL), a novel and selective BCR-ABL1 tyrosine kinase inhibitor, has shown pre-clinical and phase I activity and safety in chronic myeloid leukemia.This phase II study investigated the efficacy and safety of radotinib in Philadelphia chromosome-positive chronic phase-chronic myeloid leukemia patients with resistance and/or intoleran

read more

Relay-Assisted D2D Underlay Cellular Network Analysis Using Stochastic Geometry: Overview and Future Directions

Device-to-Device (D2D) communication is one of the enabling technologies for meeting the capacity requirements of the fifth-generation wireless systems (5G).It has diverse applications in traffic offloading, disaster management and content sharing, to mention a few.The network coverage and capacity further improve when relays are introduced to D2D

read more